Corindus Vascular Robotics Inc (CVRS) Short Interest Update

[ad_1]

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 12,833,085 shares, a growth of 1.5% from the February 15th total of 12,648,921 shares. Approximately 15.3% of the company’s stock are short sold. Based on an average trading volume of 658,038 shares, the days-to-cover ratio is currently 19.5 days.

In other news, Director Louis A. Cannon bought 573,798 shares of Corindus Vascular Robotics stock in a transaction that occurred on Tuesday, March 12th. The stock was bought at an average price of $1.38 per share, for a total transaction of $791,841.24. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder Hudson Executive Capital Lp bought 2,899,391 shares of Corindus Vascular Robotics stock in a transaction that occurred on Tuesday, March 12th. The stock was purchased at an average price of $1.38 per share, with a total value of $4,001,159.58. The disclosure for this purchase can be found here.

A number of hedge funds have recently bought and sold shares of CVRS. Citadel Advisors LLC lifted its stake in Corindus Vascular Robotics by 205.4% in the 3rd quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock worth $164,000 after purchasing an additional 77,829 shares in the last quarter. Virtu Financial LLC purchased a new stake in Corindus Vascular Robotics in the fourth quarter valued at approximately $64,000. Nomura Holdings Inc. raised its position in Corindus Vascular Robotics by 18.6% in the fourth quarter. Nomura Holdings Inc. now owns 1,262,445 shares of the medical equipment provider’s stock valued at $1,077,000 after purchasing an additional 198,111 shares during the period. Jane Street Group LLC purchased a new stake in Corindus Vascular Robotics in the fourth quarter valued at approximately $36,000. Finally, Millennium Management LLC raised its position in Corindus Vascular Robotics by 1.0% in the fourth quarter. Millennium Management LLC now owns 7,088,692 shares of the medical equipment provider’s stock valued at $5,955,000 after purchasing an additional 68,250 shares during the period.

NYSEAMERICAN:CVRS opened at $2.26 on Wednesday. Corindus Vascular Robotics has a 52 week low of $0.70 and a 52 week high of $2.31.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last posted its quarterly earnings data on Tuesday, March 12th. The medical equipment provider reported ($0.04) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.04). The firm had revenue of $4.67 million during the quarter, compared to analyst estimates of $5.60 million.

COPYRIGHT VIOLATION WARNING: “Corindus Vascular Robotics Inc (CVRS) Short Interest Update” was posted by Fairfield Current and is the sole property of of Fairfield Current. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://www.fairfieldcurrent.com/news/2019/03/20/corindus-vascular-robotics-inc-cvrs-short-interest-update.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.